Back
KalVista Pharmaceuticals Vs. REV Group Industry Stock Comparison
Sell
48
KALV
KalVista Pharmaceuticals
Last Price:
9.11
Seasonality Move:
13.48%
Buy
74
REVG
REV Group
Last Price:
33.73
Seasonality Move:
2.81%
Sell
48
KalVista Pharmaceuticals (KALV)
is a Sell
Is KalVista Pharmaceuticals a Buy, Sell or Hold?
- The current KalVista Pharmaceuticals [KALV] share price is $9.09. The Score for KALV is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- KALV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
74
REV Group (REVG)
is a Buy
Is REV Group a Buy, Sell or Hold?
- The current REV Group [REVG] share price is $33.69. The Score for REVG is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- REVG is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
KALV Stock Price Chart
What is KalVista Pharmaceuticals's stock price today?
-
The KalVista Pharmaceuticals share price today is $9.09
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KALV is experiencing selling pressure, which indicates risk of future bearish movement.
REVG Stock Price Chart
KALV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.4 | Sell |
Relative Strength Index (14 RSI): | 39.49 | Sell |
Chaikin Money Flow: | -201521 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.22 - 10.68) | Sell |
Bollinger Bands (100): | (10.09 - 13.11) | Sell |
REVG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.68 | Buy |
Relative Strength Index (14 RSI): | 65.86 | Buy |
Chaikin Money Flow: | -681203 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.5 - 31.6) | Buy |
Bollinger Bands (100): | (26.92 - 30.28) | Buy |
KALV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.52 | Sell |
20-day SMA: | 9.65 | Sell |
50-day SMA: | 10.78 | Sell |
200-day SMA: | 11.87 | Sell |
8-day EMA: | 9.47 | Sell |
20-day EMA: | 9.82 | Sell |
50-day EMA: | 10.5 | Sell |
200-day EMA: | 11.4 | Sell |
REVG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 31.23 | Buy |
20-day SMA: | 30.66 | Buy |
50-day SMA: | 29.04 | Buy |
200-day SMA: | 26.02 | Buy |
8-day EMA: | 31.23 | Buy |
20-day EMA: | 30.62 | Buy |
50-day EMA: | 29.53 | Buy |
200-day EMA: | 25.93 | Buy |
KalVista Pharmaceuticals Earnings Growth & KALV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.06 per share, an increase this year of $0.40 per share, and a decrease next year of $0.61 per share.
REV Group Earnings Growth & REVG Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.12 per share, an increase next quarter of $0.14 per share, an increase this year of $0.41 per share, and an increase next year of $0.52 per share.
KalVista Pharmaceuticals Technical Analysis
Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
REV Group Technical Analysis
Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |